SlideShare ist ein Scribd-Unternehmen logo
1 von 43
CURRENT PHARMACOLOGY & TOXICOLOGY GUIDLINES  FOR  PHARMACEUTICAL INDUSTRY Dr. Basavaraj K. Nanjwade  M.Pharm., Ph.D Associate Professor Department of Pharmaceutics KLE University BELGAUM - 10 By
Objective of the Guidance ,[object Object],[object Object],[object Object]
Background ,[object Object]
Scope of Guidance ,[object Object],[object Object]
Safety Pharmacology ,[object Object]
Pharmacology Guidance ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Pharmacology Guidance ,[object Object],[object Object],[object Object],[object Object],[object Object]
Objective of Studies ,[object Object],[object Object],[object Object]
General Considerations in Selection and Design of Safety Pharmacology Studies ,[object Object],[object Object],[object Object],[object Object],[object Object]
General Considerations in Selection and Design of Safety Pharmacology Studies ,[object Object],[object Object]
Test Systems ,[object Object],[object Object],[object Object],[object Object],[object Object]
Dose Levels or Concentrations of Test Substance ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Duration of Studies ,[object Object],[object Object],[object Object],[object Object]
Studies on Metabolites, Isomers and Finished Products ,[object Object],[object Object],[object Object]
Safety Pharmacology Core Battery ,[object Object],[object Object],[object Object]
Follow-up and Supplemental Safety Pharmacology Studies ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Conditions Under Which Studies Are Not Necessary ,[object Object],[object Object]
Conditions Under Which Studies Are Not Necessary ,[object Object],[object Object],[object Object]
Timing of Safety Pharmacology Studies in Relation to Clinical Development   ,[object Object],[object Object],[object Object],[object Object]
Application of Good Laboratory Practice ,[object Object],[object Object],[object Object],[object Object]
TOXICOLOGY ,[object Object]
Recommended Toxicology Testing   ,[object Object],[object Object],[object Object],[object Object],[object Object]
Recommended Toxicology Testing ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Genetic toxicity tests ,[object Object],[object Object],[object Object]
Short-term toxicity studies with rodents ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Short-term toxicity studies with rodents ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Short-term toxicity studies with rodents ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Short-term toxicity studies with rodents ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Short-term toxicity studies with rodents ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Chronic toxicity or Combined chronic toxicity/carcinogenicity studies with rodents ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Chronic toxicity or Combined chronic toxicity/carcinogenicity studies with rodents ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Reproduction studies ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Reproduction studies ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Reproduction studies ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Reproduction studies ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Reproduction studies ,[object Object],[object Object],[object Object],[object Object],[object Object]
Development toxicity studies ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Development toxicity studies ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Metabolism and Pharmacokinetic studies ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Metabolism and Pharmacokinetic studies ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Human studies ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Human studies ,[object Object],[object Object],[object Object],[object Object]
[object Object],E-mail: bknanjwade@yahoo.co.in

Weitere ähnliche Inhalte

Was ist angesagt?

Alternative methods to animal toxicity testing
Alternative methods to animal toxicity testingAlternative methods to animal toxicity testing
Alternative methods to animal toxicity testingSanchit Dhankhar
 
Toxicology & Regulatory Guidelines for Conducting Toxicity Study
Toxicology & Regulatory Guidelines for Conducting Toxicity StudyToxicology & Regulatory Guidelines for Conducting Toxicity Study
Toxicology & Regulatory Guidelines for Conducting Toxicity StudyJanhaviBurade
 
test item characterization of regulatory of toxicological studies
test item characterization of regulatory of toxicological studies test item characterization of regulatory of toxicological studies
test item characterization of regulatory of toxicological studies SonaliJain736101
 
OECD Guideline For Acute oral toxicity (TG 423)
OECD Guideline For Acute oral toxicity (TG 423)OECD Guideline For Acute oral toxicity (TG 423)
OECD Guideline For Acute oral toxicity (TG 423)Naveen K L
 
Regulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ichRegulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ichAnimatedWorld
 
Safety pharmacology studies
Safety pharmacology studies Safety pharmacology studies
Safety pharmacology studies Santosh Sai
 
IND Enabling Studies by Kashikant Yadav
IND Enabling Studies by Kashikant YadavIND Enabling Studies by Kashikant Yadav
IND Enabling Studies by Kashikant YadavKashikant Yadav
 
Assignment on Toxicokinetics
Assignment on ToxicokineticsAssignment on Toxicokinetics
Assignment on ToxicokineticsDeepak Kumar
 
Reproductive toxicology studies ACCORDING TO OECD guidlines 422
Reproductive toxicology  studies ACCORDING TO OECD guidlines 422 Reproductive toxicology  studies ACCORDING TO OECD guidlines 422
Reproductive toxicology studies ACCORDING TO OECD guidlines 422 SONALPANDE5
 
Male and female reproductive toxicology
Male and female reproductive toxicologyMale and female reproductive toxicology
Male and female reproductive toxicologyKhadga Raj
 
List of studies needed for IND submission
List of studies needed for IND submissionList of studies needed for IND submission
List of studies needed for IND submissionShivanshu Bajaj
 
toxicokinetics and saturation kinetics
toxicokinetics and saturation kineticstoxicokinetics and saturation kinetics
toxicokinetics and saturation kineticspharmacistnitish
 
Assignment on Reproductive toxicology studies
Assignment on Reproductive toxicology studiesAssignment on Reproductive toxicology studies
Assignment on Reproductive toxicology studiesDeepak Kumar
 
Safety Pharmacology
Safety PharmacologySafety Pharmacology
Safety PharmacologyPavana K A
 
Alternative methods to animal toxicity testing
Alternative methods to        animal toxicity testingAlternative methods to        animal toxicity testing
Alternative methods to animal toxicity testingSachin Sharma
 
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptxTOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptxAnmolkanda06
 
Skin sensitisation (OECD: 406).
Skin sensitisation (OECD: 406).Skin sensitisation (OECD: 406).
Skin sensitisation (OECD: 406).Dr Ajay Mandal
 
IND Enabling Studies (IND)
IND Enabling Studies  (IND)IND Enabling Studies  (IND)
IND Enabling Studies (IND)Anurag Chourasia
 

Was ist angesagt? (20)

Alternative methods to animal toxicity testing
Alternative methods to animal toxicity testingAlternative methods to animal toxicity testing
Alternative methods to animal toxicity testing
 
Toxicology & Regulatory Guidelines for Conducting Toxicity Study
Toxicology & Regulatory Guidelines for Conducting Toxicity StudyToxicology & Regulatory Guidelines for Conducting Toxicity Study
Toxicology & Regulatory Guidelines for Conducting Toxicity Study
 
test item characterization of regulatory of toxicological studies
test item characterization of regulatory of toxicological studies test item characterization of regulatory of toxicological studies
test item characterization of regulatory of toxicological studies
 
OECD Guideline For Acute oral toxicity (TG 423)
OECD Guideline For Acute oral toxicity (TG 423)OECD Guideline For Acute oral toxicity (TG 423)
OECD Guideline For Acute oral toxicity (TG 423)
 
Regulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ichRegulatory guidelines for conducting toxicity studies by ich
Regulatory guidelines for conducting toxicity studies by ich
 
REPRODUCTIVE TOXICITY STUDIES
REPRODUCTIVE TOXICITY STUDIESREPRODUCTIVE TOXICITY STUDIES
REPRODUCTIVE TOXICITY STUDIES
 
Safety pharmacology studies
Safety pharmacology studies Safety pharmacology studies
Safety pharmacology studies
 
IND Enabling Studies by Kashikant Yadav
IND Enabling Studies by Kashikant YadavIND Enabling Studies by Kashikant Yadav
IND Enabling Studies by Kashikant Yadav
 
Assignment on Toxicokinetics
Assignment on ToxicokineticsAssignment on Toxicokinetics
Assignment on Toxicokinetics
 
Reproductive toxicology studies ACCORDING TO OECD guidlines 422
Reproductive toxicology  studies ACCORDING TO OECD guidlines 422 Reproductive toxicology  studies ACCORDING TO OECD guidlines 422
Reproductive toxicology studies ACCORDING TO OECD guidlines 422
 
Male and female reproductive toxicology
Male and female reproductive toxicologyMale and female reproductive toxicology
Male and female reproductive toxicology
 
List of studies needed for IND submission
List of studies needed for IND submissionList of studies needed for IND submission
List of studies needed for IND submission
 
toxicokinetics and saturation kinetics
toxicokinetics and saturation kineticstoxicokinetics and saturation kinetics
toxicokinetics and saturation kinetics
 
Assignment on Reproductive toxicology studies
Assignment on Reproductive toxicology studiesAssignment on Reproductive toxicology studies
Assignment on Reproductive toxicology studies
 
Safety Pharmacology
Safety PharmacologySafety Pharmacology
Safety Pharmacology
 
Alternative methods to animal toxicity testing
Alternative methods to        animal toxicity testingAlternative methods to        animal toxicity testing
Alternative methods to animal toxicity testing
 
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptxTOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
TOXICOKINETICS EVALUATION IN PRECLINICAL STUDIES.pptx
 
Skin sensitisation (OECD: 406).
Skin sensitisation (OECD: 406).Skin sensitisation (OECD: 406).
Skin sensitisation (OECD: 406).
 
IND Enabling Studies (IND)
IND Enabling Studies  (IND)IND Enabling Studies  (IND)
IND Enabling Studies (IND)
 
Safety pharmacology
Safety pharmacologySafety pharmacology
Safety pharmacology
 

Andere mochten auch

Pharmacology/Toxicology information to submit an IND for an anticancer drug
Pharmacology/Toxicology information to submit an IND for an anticancer drugPharmacology/Toxicology information to submit an IND for an anticancer drug
Pharmacology/Toxicology information to submit an IND for an anticancer drugshabeel pn
 
Animal toxicology studies
Animal toxicology studiesAnimal toxicology studies
Animal toxicology studiesswati2084
 
NEUROBEHAVIORAL PERFORMANCE AFTER LEAD EXPOSURE
NEUROBEHAVIORAL PERFORMANCE AFTER LEAD EXPOSURENEUROBEHAVIORAL PERFORMANCE AFTER LEAD EXPOSURE
NEUROBEHAVIORAL PERFORMANCE AFTER LEAD EXPOSURESiti Mastura
 
Efficacy of Occupational Therapy on Neuro-Behavioral Deficits, Activties of D...
Efficacy of Occupational Therapy on Neuro-Behavioral Deficits, Activties of D...Efficacy of Occupational Therapy on Neuro-Behavioral Deficits, Activties of D...
Efficacy of Occupational Therapy on Neuro-Behavioral Deficits, Activties of D...Snigdha Samantray
 
Screening methods of immunomodulatory drugs
Screening methods of  immunomodulatory drugsScreening methods of  immunomodulatory drugs
Screening methods of immunomodulatory drugsPrafulla Tiwari
 
Teratogenicity dr.elza
Teratogenicity dr.elzaTeratogenicity dr.elza
Teratogenicity dr.elzaElza Emmannual
 
Chronic toxicity studies a brief outlook
Chronic toxicity studies a brief outlookChronic toxicity studies a brief outlook
Chronic toxicity studies a brief outlookRxVichuZ
 
Schedule y -_priti_gupta
Schedule y -_priti_guptaSchedule y -_priti_gupta
Schedule y -_priti_guptaPriti Gupta
 
Toxicology & risk
Toxicology & riskToxicology & risk
Toxicology & riskElisa
 
Comparison of Pharmacology and Toxicology
Comparison of Pharmacology and ToxicologyComparison of Pharmacology and Toxicology
Comparison of Pharmacology and Toxicologyshabeel pn
 
Design And Conduct Safety Pharmacology And Toxicology Study For Pharmaceuticals
Design And Conduct Safety Pharmacology And Toxicology Study For PharmaceuticalsDesign And Conduct Safety Pharmacology And Toxicology Study For Pharmaceuticals
Design And Conduct Safety Pharmacology And Toxicology Study For PharmaceuticalsProf. Dr. Basavaraj Nanjwade
 
Fundamentals Of Genetic Toxicology In The Pharmaceutical Industry Sept 2010
Fundamentals Of Genetic Toxicology In The Pharmaceutical Industry Sept 2010Fundamentals Of Genetic Toxicology In The Pharmaceutical Industry Sept 2010
Fundamentals Of Genetic Toxicology In The Pharmaceutical Industry Sept 2010TigerTox
 
Toxicology-History
Toxicology-HistoryToxicology-History
Toxicology-Historytmondol
 

Andere mochten auch (20)

Pharmacology/Toxicology information to submit an IND for an anticancer drug
Pharmacology/Toxicology information to submit an IND for an anticancer drugPharmacology/Toxicology information to submit an IND for an anticancer drug
Pharmacology/Toxicology information to submit an IND for an anticancer drug
 
INTRODUCTION TO TOXICOLOGY
INTRODUCTION TO TOXICOLOGYINTRODUCTION TO TOXICOLOGY
INTRODUCTION TO TOXICOLOGY
 
Animal toxicology studies
Animal toxicology studiesAnimal toxicology studies
Animal toxicology studies
 
NEUROBEHAVIORAL PERFORMANCE AFTER LEAD EXPOSURE
NEUROBEHAVIORAL PERFORMANCE AFTER LEAD EXPOSURENEUROBEHAVIORAL PERFORMANCE AFTER LEAD EXPOSURE
NEUROBEHAVIORAL PERFORMANCE AFTER LEAD EXPOSURE
 
Efficacy of Occupational Therapy on Neuro-Behavioral Deficits, Activties of D...
Efficacy of Occupational Therapy on Neuro-Behavioral Deficits, Activties of D...Efficacy of Occupational Therapy on Neuro-Behavioral Deficits, Activties of D...
Efficacy of Occupational Therapy on Neuro-Behavioral Deficits, Activties of D...
 
Screening methods of immunomodulatory drugs
Screening methods of  immunomodulatory drugsScreening methods of  immunomodulatory drugs
Screening methods of immunomodulatory drugs
 
Using Machine Intelligence to Perform Predictive Toxicology
Using Machine Intelligence to Perform Predictive ToxicologyUsing Machine Intelligence to Perform Predictive Toxicology
Using Machine Intelligence to Perform Predictive Toxicology
 
Teratogenicity dr.elza
Teratogenicity dr.elzaTeratogenicity dr.elza
Teratogenicity dr.elza
 
Role of fob in FB extraction
Role of fob in FB extractionRole of fob in FB extraction
Role of fob in FB extraction
 
Chronic toxicity studies a brief outlook
Chronic toxicity studies a brief outlookChronic toxicity studies a brief outlook
Chronic toxicity studies a brief outlook
 
Schedule y
Schedule ySchedule y
Schedule y
 
Schedule y -_priti_gupta
Schedule y -_priti_guptaSchedule y -_priti_gupta
Schedule y -_priti_gupta
 
Toxicology & risk
Toxicology & riskToxicology & risk
Toxicology & risk
 
Comparison of Pharmacology and Toxicology
Comparison of Pharmacology and ToxicologyComparison of Pharmacology and Toxicology
Comparison of Pharmacology and Toxicology
 
Design And Conduct Safety Pharmacology And Toxicology Study For Pharmaceuticals
Design And Conduct Safety Pharmacology And Toxicology Study For PharmaceuticalsDesign And Conduct Safety Pharmacology And Toxicology Study For Pharmaceuticals
Design And Conduct Safety Pharmacology And Toxicology Study For Pharmaceuticals
 
Pravin fianl
Pravin fianlPravin fianl
Pravin fianl
 
Fundamentals Of Genetic Toxicology In The Pharmaceutical Industry Sept 2010
Fundamentals Of Genetic Toxicology In The Pharmaceutical Industry Sept 2010Fundamentals Of Genetic Toxicology In The Pharmaceutical Industry Sept 2010
Fundamentals Of Genetic Toxicology In The Pharmaceutical Industry Sept 2010
 
Toxicology-History
Toxicology-HistoryToxicology-History
Toxicology-History
 
Schedule y, mk sharma
Schedule y, mk sharmaSchedule y, mk sharma
Schedule y, mk sharma
 
Cancer carcinogens
Cancer carcinogensCancer carcinogens
Cancer carcinogens
 

Ähnlich wie Current Pharmacology & Toxicology Guidlines For Pharmaceutical Industry

Safety pharmacology studies in drug development
Safety pharmacology studies in drug developmentSafety pharmacology studies in drug development
Safety pharmacology studies in drug developmentAnkita
 
Phase clinicaltrial
Phase clinicaltrialPhase clinicaltrial
Phase clinicaltriallillibabu
 
Safety pharmacology
Safety pharmacologySafety pharmacology
Safety pharmacologySourabhAtak
 
Safety s7 a-seminar-ppt-pptx
Safety s7 a-seminar-ppt-pptxSafety s7 a-seminar-ppt-pptx
Safety s7 a-seminar-ppt-pptxSanthanakumar21
 
Pharmacological Approach to Drug Discovery
Pharmacological Approach to Drug DiscoveryPharmacological Approach to Drug Discovery
Pharmacological Approach to Drug DiscoverySuhas Reddy C
 
EXTRAPOLATION OF IN VITRO DATA TO PRECLINICAL
EXTRAPOLATION OF IN VITRO DATA TO PRECLINICALEXTRAPOLATION OF IN VITRO DATA TO PRECLINICAL
EXTRAPOLATION OF IN VITRO DATA TO PRECLINICALTMU
 
Stages of drug development
Stages of drug developmentStages of drug development
Stages of drug developmentmeethy
 
various approaches to drug discovery
various approaches to drug discoveryvarious approaches to drug discovery
various approaches to drug discoveryaiswarya thomas
 
Toxicological Approach to Drug Discovery
Toxicological Approach to Drug DiscoveryToxicological Approach to Drug Discovery
Toxicological Approach to Drug DiscoverySuhas Reddy C
 
Pharmacological Approach for drug development
Pharmacological Approach for drug developmentPharmacological Approach for drug development
Pharmacological Approach for drug developmentDr Duggirala Mahendra
 
PHAR2202 Drug Design And Analytical Methods.docx
PHAR2202 Drug Design And Analytical Methods.docxPHAR2202 Drug Design And Analytical Methods.docx
PHAR2202 Drug Design And Analytical Methods.docxwrite5
 
Drug development process
Drug development process Drug development process
Drug development process Zobayer Hossain
 

Ähnlich wie Current Pharmacology & Toxicology Guidlines For Pharmaceutical Industry (20)

Safety pharmacology
Safety pharmacologySafety pharmacology
Safety pharmacology
 
Safety pharmacology studies in drug development
Safety pharmacology studies in drug developmentSafety pharmacology studies in drug development
Safety pharmacology studies in drug development
 
Phase clinicaltrial
Phase clinicaltrialPhase clinicaltrial
Phase clinicaltrial
 
Safety pharmacology
Safety pharmacologySafety pharmacology
Safety pharmacology
 
Safety s7 a-seminar-ppt-pptx
Safety s7 a-seminar-ppt-pptxSafety s7 a-seminar-ppt-pptx
Safety s7 a-seminar-ppt-pptx
 
Safety Pharmacology Studies ICH guideline S7A
Safety Pharmacology Studies ICH guideline S7ASafety Pharmacology Studies ICH guideline S7A
Safety Pharmacology Studies ICH guideline S7A
 
Pharmacological Approach to Drug Discovery
Pharmacological Approach to Drug DiscoveryPharmacological Approach to Drug Discovery
Pharmacological Approach to Drug Discovery
 
Drug development process
Drug development processDrug development process
Drug development process
 
Phase 1 clinical trial
Phase 1 clinical trialPhase 1 clinical trial
Phase 1 clinical trial
 
EXTRAPOLATION OF IN VITRO DATA TO PRECLINICAL
EXTRAPOLATION OF IN VITRO DATA TO PRECLINICALEXTRAPOLATION OF IN VITRO DATA TO PRECLINICAL
EXTRAPOLATION OF IN VITRO DATA TO PRECLINICAL
 
Stages of drug development
Stages of drug developmentStages of drug development
Stages of drug development
 
various approaches to drug discovery
various approaches to drug discoveryvarious approaches to drug discovery
various approaches to drug discovery
 
Drug development
Drug developmentDrug development
Drug development
 
Toxicological Approach to Drug Discovery
Toxicological Approach to Drug DiscoveryToxicological Approach to Drug Discovery
Toxicological Approach to Drug Discovery
 
Pharmacological Approach for drug development
Pharmacological Approach for drug developmentPharmacological Approach for drug development
Pharmacological Approach for drug development
 
Pre Clinical Studies
Pre Clinical StudiesPre Clinical Studies
Pre Clinical Studies
 
Molecule to medicine
Molecule to medicineMolecule to medicine
Molecule to medicine
 
Phase 1 protocol
Phase 1 protocolPhase 1 protocol
Phase 1 protocol
 
PHAR2202 Drug Design And Analytical Methods.docx
PHAR2202 Drug Design And Analytical Methods.docxPHAR2202 Drug Design And Analytical Methods.docx
PHAR2202 Drug Design And Analytical Methods.docx
 
Drug development process
Drug development process Drug development process
Drug development process
 

Mehr von Prof. Dr. Basavaraj Nanjwade

Good laboratory practices for pharmaceuticals and biopharmaceuticals
Good laboratory practices for pharmaceuticals  and  biopharmaceuticalsGood laboratory practices for pharmaceuticals  and  biopharmaceuticals
Good laboratory practices for pharmaceuticals and biopharmaceuticalsProf. Dr. Basavaraj Nanjwade
 
Packaging and Stability Requirements for Pharmaceuticals
Packaging and Stability Requirements for PharmaceuticalsPackaging and Stability Requirements for Pharmaceuticals
Packaging and Stability Requirements for PharmaceuticalsProf. Dr. Basavaraj Nanjwade
 
QbD for Product Development of Solid Semisolid and Liquid Dosage Forms
QbD for Product Development of Solid Semisolid and Liquid Dosage FormsQbD for Product Development of Solid Semisolid and Liquid Dosage Forms
QbD for Product Development of Solid Semisolid and Liquid Dosage FormsProf. Dr. Basavaraj Nanjwade
 
Development, safety and stability of biotechnological and biological products
Development, safety and stability of biotechnological and biological productsDevelopment, safety and stability of biotechnological and biological products
Development, safety and stability of biotechnological and biological productsProf. Dr. Basavaraj Nanjwade
 
Clinical studies and trials on traditional medicine and natural products
Clinical studies and trials on traditional medicine and natural productsClinical studies and trials on traditional medicine and natural products
Clinical studies and trials on traditional medicine and natural productsProf. Dr. Basavaraj Nanjwade
 

Mehr von Prof. Dr. Basavaraj Nanjwade (20)

COVID-19 and Novel Drug Delivery System.ppt
COVID-19 and Novel Drug Delivery System.pptCOVID-19 and Novel Drug Delivery System.ppt
COVID-19 and Novel Drug Delivery System.ppt
 
Good laboratory practices for pharmaceuticals and biopharmaceuticals
Good laboratory practices for pharmaceuticals  and  biopharmaceuticalsGood laboratory practices for pharmaceuticals  and  biopharmaceuticals
Good laboratory practices for pharmaceuticals and biopharmaceuticals
 
Opportunities and future for pharmacist
Opportunities and future for pharmacistOpportunities and future for pharmacist
Opportunities and future for pharmacist
 
Opportunities and future for pharmacist
Opportunities and future for pharmacistOpportunities and future for pharmacist
Opportunities and future for pharmacist
 
Novel drug delivery system
Novel drug delivery systemNovel drug delivery system
Novel drug delivery system
 
Packaging and Stability Requirements for Pharmaceuticals
Packaging and Stability Requirements for PharmaceuticalsPackaging and Stability Requirements for Pharmaceuticals
Packaging and Stability Requirements for Pharmaceuticals
 
QbD for Product Development of Solid Semisolid and Liquid Dosage Forms
QbD for Product Development of Solid Semisolid and Liquid Dosage FormsQbD for Product Development of Solid Semisolid and Liquid Dosage Forms
QbD for Product Development of Solid Semisolid and Liquid Dosage Forms
 
Opportunities and Future for Pharma Buddies
Opportunities and Future for Pharma BuddiesOpportunities and Future for Pharma Buddies
Opportunities and Future for Pharma Buddies
 
Development of Clinical Formulation
Development of Clinical FormulationDevelopment of Clinical Formulation
Development of Clinical Formulation
 
QbD for Pharma Products Development
QbD for Pharma Products DevelopmentQbD for Pharma Products Development
QbD for Pharma Products Development
 
Development, safety and stability of biotechnological and biological products
Development, safety and stability of biotechnological and biological productsDevelopment, safety and stability of biotechnological and biological products
Development, safety and stability of biotechnological and biological products
 
Clinical studies and trials on traditional medicine and natural products
Clinical studies and trials on traditional medicine and natural productsClinical studies and trials on traditional medicine and natural products
Clinical studies and trials on traditional medicine and natural products
 
Clinical drug design
Clinical drug designClinical drug design
Clinical drug design
 
Clinical drug development
Clinical drug developmentClinical drug development
Clinical drug development
 
Clinical drug design
Clinical drug designClinical drug design
Clinical drug design
 
Solid dosage forms (tablets)
Solid dosage forms (tablets)Solid dosage forms (tablets)
Solid dosage forms (tablets)
 
Solid dosage forms (capsules)
Solid dosage forms (capsules)Solid dosage forms (capsules)
Solid dosage forms (capsules)
 
Preparations in pharmacy of hospital
Preparations in pharmacy of hospitalPreparations in pharmacy of hospital
Preparations in pharmacy of hospital
 
Injectable solutions
Injectable solutionsInjectable solutions
Injectable solutions
 
Aerosols
AerosolsAerosols
Aerosols
 

Kürzlich hochgeladen

Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfchloefrazer622
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpinRaunakKeshri1
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxVishalSingh1417
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingTeacherCyreneCayanan
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Celine George
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3JemimahLaneBuaron
 
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...Sapna Thakur
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsTechSoup
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdfSoniaTolstoy
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdfQucHHunhnh
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationnomboosow
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphThiyagu K
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfAdmir Softic
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 

Kürzlich hochgeladen (20)

Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
Arihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdfArihant handbook biology for class 11 .pdf
Arihant handbook biology for class 11 .pdf
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
Student login on Anyboli platform.helpin
Student login on Anyboli platform.helpinStudent login on Anyboli platform.helpin
Student login on Anyboli platform.helpin
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writing
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3Q4-W6-Restating Informational Text Grade 3
Q4-W6-Restating Informational Text Grade 3
 
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
BAG TECHNIQUE Bag technique-a tool making use of public health bag through wh...
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdfBASLIQ CURRENT LOOKBOOK  LOOKBOOK(1) (1).pdf
BASLIQ CURRENT LOOKBOOK LOOKBOOK(1) (1).pdf
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
1029 - Danh muc Sach Giao Khoa 10 . pdf
1029 -  Danh muc Sach Giao Khoa 10 . pdf1029 -  Danh muc Sach Giao Khoa 10 . pdf
1029 - Danh muc Sach Giao Khoa 10 . pdf
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communication
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
Key note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdfKey note speaker Neum_Admir Softic_ENG.pdf
Key note speaker Neum_Admir Softic_ENG.pdf
 
The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 

Current Pharmacology & Toxicology Guidlines For Pharmaceutical Industry

  • 1. CURRENT PHARMACOLOGY & TOXICOLOGY GUIDLINES FOR PHARMACEUTICAL INDUSTRY Dr. Basavaraj K. Nanjwade M.Pharm., Ph.D Associate Professor Department of Pharmaceutics KLE University BELGAUM - 10 By
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 9.
  • 10.
  • 11.
  • 12.
  • 13.
  • 14.
  • 15.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.
  • 24.
  • 25.
  • 26.
  • 27.
  • 28.
  • 29.
  • 30.
  • 31.
  • 32.
  • 33.
  • 34.
  • 35.
  • 36.
  • 37.
  • 38.
  • 39.
  • 40.
  • 41.
  • 42.
  • 43.